2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile has been researched along with Coxsackie Virus Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bargar, TM; Dulworth, JK; Goralski, CT; Johnston, H; Markley, LD; Steward, DL; Tong, YC; Vinogradoff, AP; Wood, SG | 1 |
| Galabov, AS; Stoyanova, A | 1 |
| Dimitrov, V; Dobrikov, G; Galabov, AS; Nikolova, I; Philipov, S; Pürstinger, G; Stoyanova, A | 1 |
3 other study(ies) available for 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile and Coxsackie Virus Infections
| Article | Year |
|---|---|
Antipicornavirus activity of substituted phenoxybenzenes and phenoxypyridines.
Topics: Animals; Antiviral Agents; Benzene Derivatives; Cell Division; Cell Survival; Coxsackievirus Infections; Cytopathogenic Effect, Viral; Enterovirus; HeLa Cells; Humans; Mice; Picornaviridae; Pyridines; Rhinovirus; Structure-Activity Relationship | 1986 |
Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.
Topics: Animals; Antiviral Agents; Apomorphine; Cell Line; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Nitriles; Oxadiazoles; Oxazoles; Virus Replication | 2020 |
Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.
Topics: Animals; Antiviral Agents; Apomorphine; Cells, Cultured; Coxsackievirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Oxadiazoles; Oxazoles; Virus Replication | 2015 |